Electra Therapeutics Stock (NASDAQ:ETRA)
Previous Close
$8.61
52W Range
$8.50 - $15.50
50D Avg
$10.53
200D Avg
$10.53
Market Cap
$190.88M
Avg Vol (3M)
$807.28K
Beta
-
Div Yield
-
ETRA Company Profile
Electra Therapeutics, Inc. is a clinical stage biotechnology company. It is engaged in therapies against novel targets for diseases in immunology and cancer. The company was founded by Adam Rosenthal on October 11, 2018 and is headquartered in South San Francisco, CA.